Biguanides include
Metformin
Mechanism of action of metformin
Liver (Major): Inhibits Gluconeogenesis & Glycogenolysis.
Muscle: Increases insulin sensitivity & Glucose uptake.
Gut: Delays glucose absorption.
Result of the effects of metformin
Lowers fasting glucose without causing hypoglycemia (Euglycemic)
Theraputic uses of Metformin
▪ As the initial drug of choice for type 2 diabetes (may be used alone or in combination with other oral agents or insulin).
▪ Used in the treatment of polycystic ovary syndrome, as it reduces insulin resistance
Adverse effects of Metformin
1) GI upset: metallic taste, anorexia, diarrhoea
2) Vitamin B12 deficiency: Interferes with absorption in ileum
3) Lactic Acidosis: Rare but fatal. (Risk in renal failure)
First-line therapy for Type 2 DM worldwide
Metformin
Key feature of metformin
Antihyperglycemic (Euglycemic). Does not cause hypoglycemia when used alone.
Thiazolidinediones (TZDs) include
Pioglitazone
Mechanism of action of pioglitazone
Selective agonists of PPAR-γ (Peroxisome ProliferatorActivated Receptor-gamma) regulates the transcription of
genes involved in CHO and lipid metabolism, synthesis of
GLUT-4 and other genes involved in insulin sensitivity.
“Insulin Sensitizers” enhance insulin sensitivity in muscle & fat
Thiazolidinediones (TZDs)
Onset of pioglitazone
slow(gene transcription)
Theraputic uses of pioglitazone
Used as a second- or third line agent for type 2 diabetes
Adverse effects of pioglitazone
▪ Fluid retention/edema( congestive heart failure risk)
▪ Weight gain
▪ Bone fracture risk
▪ Bladder Cancer: Potential link with long-term Pioglitazone.
Sulfonylureas include
Glipizide & Glimepiride
Primary action of Sulfonylureas
Increase insulin secretion from pancreatic β-cells
(independent of glucose)
An active metabolite of sulfonylureas
Glibenclamide
Mechanism of action of sulfonylureas
Bind to the SUR1 subunit on ATP-sensitive K+ channels on
pancreatic β-cells → membrane depolarization → Ca2+ influx →
insulin release irrespective of glucose level
Adverse effects of sulfonylureas
▪ Hypoglycemia (especially with Elderly, Renal Failure, Skipped
meals, Long-acting agents)
▪ Weight gain
▪ Secondary Failure: Initial response is good, but efficacy declines as
β-cell mass fails over time (5-10% fail/year)
Salicylates (Aspirin), Sulfonamides given alongside sulfonylureas can result in
Displacement from ablumin = increase in free drug = hypoglycemia
Cimetidine, Ketoconazole, Warfarin given alonside sulfonylureas can result in
CYP enzyme inhibition= increase plasma levels = hypoglycemia
Rifampicin, Phenytoin given alongside sulfonylureas can result in
CYP enzyme induction= decrease efficacy = hyperglycemia
Steroids, thiazides given alonside sulfonylureas can result in
Physiological antagonism = increase glucose = hyperglycemia
Meglitinides include
Repaglinide
Repaglinide is metabolized and excereted
They are metabolized in the liver and are excreted through the bile